Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose —the randomized controlled HOMe aFers study

In patients with iron deficiency anemia, ferric carboxymaltose (FCM) and ferric derisomaltose (FDI) allow high-dose iron repletion. While FCM is reported to induce hypophosphatemia, the frequency of hypophosph...

Source: BMC Medicine - July 13, 2020 Category: Internal Medicine Authors: I. E. Emrich, F. Lizzi, J. D. Siegel, S. Seiler-Mussler, C. Ukena, D. Kaddu-Mulindwa, R. D ’Amelio, S. Wagenpfeil, V. M. Brandenburg, M. Böhm, D. Fliser and G. H. Heine Tags: Research article Source Type: research